The PennZone

  • Home
  • Non-profit
  • Business
  • Construction
  • Entertainment
  • Education
  • Technology
  • Celebrities
  • Real Estate

Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
The PennZone/10123847

Trending...
  • The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph
  • Bishop Mary's WWDB 860 AM Show Nears Historic 250-Episode Milestone
  • Eastern Adjustment Group, LLP Provides Property Loss Advocacy and Claim Support
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ -- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.

ConneX®,  the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.

Greenphire has also continued to evolve its ClinCard solution, the industry-leading method for automating participant payments and reimbursements, driving operational efficiency for sites and improved experience for participants around the world. The ClinCard portal is now translated into 17 different languages, including French, Polish, and Spanish. The company also initiated a dedicated site training team with EU and APAC time zones supported, demonstrating its commitment and motivation to provide a high quality and user-friendly experience for sites around the world.

More on The PennZone
  • Free PDF Tools Online: Edit, Convert, Compress, Merge and Manage PDF Files in One Platform
  • Evermore Bliss Launches AI Wedding Speech Writer to Help Users Create Personalized, Heartfelt Toasts
  • Keenethics enters the ChatGPT Apps ecosystem as a new growth opportunity for businesses
  • Spring Into Your New Home at Heritage at South Brunswick
  • ULiveUSA Launches New "Moment Marketing" System Using Videos to Help Local Businesses Get More Customers

"COVID-19 was a catalyst that accelerated the clinical trial industry towards embracing technology solutions, such as ClinCard and ConneX," said Jim Murphy, CEO, Greenphire. "Sponsors, CROs and sites quickly appreciated the immense benefits of adding innovative solutions to support their trials, such as higher patient engagement and retention and improved operational efficiencies. We are proud to support this digital movement and enhance the experience for sites in every corner of the globe."

Recognized as leaders in clinical digital innovations in the United Kingdom, having their EU headquarters in Nottingham and more than 1,000 sites supported in the country, Greenphire executives have been asked to host an interactive panel on this growing trend.

Hosted by the Society for Clinical Research Sites (SCRS), the one-hour session titled: Digital Innovation in Clinical Trials: A Conversation with UK Stakeholders, will also feature the unique perspectives of clinical trial site, The University of Aberdeen, and advocate and patient engagement advisor, Trishna Bharadia.

This virtual event is scheduled for May 4, 2021 at 10:00 AM ET and will take a deep dive into current trends and how technology, together with training, is driving the future of clinical trials.

Presenters include:
  • Angela La Ronde, Panel Moderator, Director of Relationship Management, Greenphire UK
  • Trishna Bharadia, Advocate and Patient Engagement Advisor
  • Shaun Treweek, Professor, University of Aberdeen
  • Ben Gordon, Site Trainer, Greenphire UK

For more information or to register for the event visit: https://bit.ly/3tLmfws

More on The PennZone
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • HarryPotterObamaSonic10Inu (Ticker: BITCOIN) Is the Best Cryptocurrency in Global History
  • Colonial Nissan Highlights 2026 Armada after Major Best Buy Award Win
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph

Greenphire is also a co-sponsor of the 11th Annual OCT Europe (Outsourcing in Clinical Trials). The virtual event, hosted from May 5-6, 2021, will center on how to leverage partnerships and expertise to maximize trial success. For more information, visit: https://www.arena-international.com/octeurope/

About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire's EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Alyson Kuritz
908-892-7149
[email protected]

SOURCE Greenphire

Related Links

http://www.greenphire.com
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Engineering leaders from industry, academia to gather at IISE Annual Conference & Expo in Arlington, Texas
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Authentise Launches "Whisper," Agentic AI Backbone for Engineering & Manufacturing
  • Old Economy Village Invites Visitors to Explore its 2026 Event Season
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • Grange Insurance Association to Rebrand as Granwest Insurance on July 1, 2026
  • Dr. Rosendo Icochea, MD Recognized for Contributions to Surgical Education and Medical Research
  • Giftella Launches AI Gift-Finder App That Replaces Guesswork With Personalized Picks in Seconds
  • Beverly.io Announces Nationwide Expansion and Poppins Payroll Partnership for Families
  • Collectors gathered 'round the playing circle to compete for the rarest and best examples at Morphy's April 11 Premier Marbles auction
  • New Book: The Battle for Truth and Shadows - Guardians of Light - Epic Fantasy Unveils a War Between Light and Deception
  • Clash of Prompts: The World's First AI Prompt Battle Royale
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
  • MainConcept Announces Multiview Encoding for Apple Immersive Video
  • CCHR Rejects Global Psychiatric Push to Electroshock Children
  • iVAM2-ST2110 to Simplify IP Transitions and Reduce Monitoring Complexity
  • Americans Leave Behind or Discard 42% of Their Belongings When Moving Out for the First Time, Talker Research Finds
  • Central Florida Luxury Real Estate Firm DANHOLM COLLECTION Partners with Luxury Presence to Expand Global Buyer Reach
  • Advantage Marketing Launches 3-Minute Assessment to Help SMBs Diagnose and Fix Marketing Gaps

Popular on PennZone

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 247
  • Actress/Model Raelia Lewis Building a Powerful Name in Entertainment and Fashion - 122
  • 300 Episodes. One Mission: Brother Marcus Ignites a Global Movement of Inspiration
  • R&B Artist Mike Davis Announces Debut Full-Length Album Full Circle, Releasing April 7
  • Bethany Nikitenko Elected Board Vice President of Philadelphia VIP
  • From Speech Therapy to 300+ Episodes: Brother Marcus Turns His Voice Into a Movement Launching a 24/7 Inspiration Radio Network on Day 100 of the Year
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
  • The Finger Comb, a Dream Inspired 3-in-1 Styling Tool introduced by Andrea L. Randolph
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • Porter's Day Care Empowers Philadelphia's Future Through 45+ Years of Excellence

Similar on PennZone

  • Uxur Taxi Unveils Luxury 3,000‑Mile Private Driver Service for Nationwide Travel
  • ULiveUSA Launches New "Moment Marketing" System Using Videos to Help Local Businesses Get More Customers
  • UK Financial Ltd Launches UKFL Premier One as Its Official Broadcast Channel for Premium Content, Podcasts & Independent Expert Analysis
  • Dual-Engine Growth Strategy Unleashed Targeting a $9.1B Market and the Exploding AI Biotech Revolution: KALA BIO (N A S D A Q: KALA)
  • Dog Grooming Businesses Turn to Performance-Based Platforms to Attract Local Clients
  • Revenue Optics Completes Full Commercial Buildout. A Nine-Month-Old Firm Built on 25 Years of Distribution Expertise. Five Clients From $200M to $3B
  • AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • BestDoc Launches AI Call Center for Healthcare
  • Acuvance Appoints Sandeep Sabharwal to Board of Directors, Strengthening Leadership to Support Continued Platform Growth
  • $7.6 Billion US Crypto ATM Market by 2034; California and Texas Crypto ATM Deployments for Bitcoin Bancorp (Stock Symbol: BCBC); 1000 Kiosk Inventory
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us